By Sonia McNeil Myriad Genetics Appeals Ruling on Patentability of Isolated Genes Myriad Genetics has appealed the Southern District of New York’s ruling in Association for Molecular Pathology v. USPTO. The district court invalidated seven Myriad Genetics patents relating to the human Breast Cancer Susceptibility Genes 1 and 2 (collectively, “BRCA1/2”), finding that the claimed isolated DNA is not markedly different from native DNA as it exists in nature and therefore constituted unpatentable subject matter under 35 U.S.C. § 101. ... Read More...
A student-run resource for reliable reports on the latest law and technology news
Digest Comment: Citi
By Conor H. Kennedy Editorial Policy In Citizens United v. Federal Election ...
Digest Comment: Dete
By Harry Zhou Edited by Gary Pong Editorial Policy Libel litigation against ...
Digest Comment - The
Australia Poised to Begin Internet Filtering Program Unprecedented in Scope ...
- SCOTUS holds that buying copies of books lawfully made overseas & selling in the US is A Okay (for now) | Professor Tonya M. Evans: [...] Read the full article at Jolt.law.harvard.edu [...]
- Security Letters In The Lurch » Right Thinking: [...] powers in Court because, as we saw in the Clapper decision, SCOTUS has rul ...
- Drone Strikes On Americans, WTF? Who defines when a citizen is at war with the government? | Family Survival Protocol: [...] Drone Strikes and Due Process: The Role of the Separation of Powers in Let ...
- 36 Seconds of Fame | Monk Turner's Angular Blogosphere: [...] BuzzHR, Alltop, The Jojo Show, Blakeson, Divertissement, 1709 Blog, Gulli, ...
- February 28, 2013 Non-Practicing Entity Newsclips | nonpracticingentities: [...] Manufacturers Attempt To Invoke RICO Act Fails Against Non Practicing Enti ...